SEC Filings TLDR

James A. Burke, an officer and director of Vistra Corp., has reported significant transactions involving the company's common stock. On October 27, 2025, Burke acquired 20,473 shares through an option granted on April 9, 2018. Additionally, Burke has engaged in multiple sales of common stock over the past three months,...

Charles A. Rowland Jr., a director of Viking Therapeutics, Inc., has exercised options to acquire 60,000 shares of common stock under a registered plan. The transactions occurred on October 27, 2025, with the shares acquired at a payment date of the same day. The aggregate market value of the shares is approximately $2...

Robert Gendron, an officer at Vicor Corporation, has reported significant stock transactions. On October 27, 2025, Gendron exercised stock options to acquire 1,321 shares of common stock. Additionally, he sold 2,795 shares on October 24, 2025, for $252,948.62 and 2,116 shares on October 23, 2025, for $187,649.21. These...

Sean Crilly, an officer of Vicor Corporation, has filed a Form 144 notice indicating the intent to sell 12,000 shares of common stock. The shares were acquired on March 6, 2023, through the exercise of stock options. The approximate sale date is set for October 27, 2025, with an aggregate market value of $1,075,335.60....

Martine Rothblatt, the Founder, Chairperson, and Chief Executive Officer of United Therapeutics Corp, has filed a Form 144 with the SEC. The filing details the sale of 4,000 common shares on October 27, 2025, with an aggregate market value of $1,662,173.20. The securities were acquired on March 15, 2016, through Execut...

Patrick Joseph Murphy, an officer of TransDigm Group Incorporated, has filed a Form 144 notice regarding the sale of securities. The filing indicates that Murphy plans to sell 580 shares of common stock acquired through the exercise of stock options on October 27, 2025. The aggregate market value of these shares is app...

The filing discloses that THE FORTUNA TRUST U/T/A DTD 06/01/2018, an officer of TransDigm Group Incorporated, plans to exercise stock options for 700 shares of common stock on 10/27/2025. The shares were acquired on the same date through the exercise of stock options. The aggregate market value of the shares is $951,51...

Margaret Tooth, an officer and director of Trupanion, Inc., has filed a Form 144 with the SEC detailing her planned sale of securities. The filing includes information on securities acquired through restricted stock and stock option exercises. Tooth acquired 1,442 shares of common stock on August 25, 2021, and May 25, ...

The filing details the securities transactions of Marc N. Casper, an officer and director of Thermo Fisher Scientific Inc. The notice, dated October 27, 2025, outlines the sale of 7,250 common shares acquired through an option granted on February 26, 2019. The aggregate market value of these shares is approximately $4,...

Ujjwal Kumar, a former officer of Teradyne, Inc., has filed a Form 144 to sell 2,861 shares of common stock. The shares were acquired through open market purchases and option grants. The total market value of the shares to be sold is approximately $429,150. The sale is scheduled to occur on October 27, 2025. The filing...

ZHANG KAIFU, an independent director of TAL Education Group, acquired 5,155 ADS (each representing one Class A common share) under the company's share incentive plan on October 27, 2025. The acquisition was based on the closing price of $12.60 on October 24, 2025, resulting in an aggregate market value of $64,953. The ...

PENG ALEX ZHUANGZHUANG, the President and CFO of TAL Education Group, acquired 15,294 ADS (each representing one Class A common share) under the company's share incentive plan on October 27, 2025. The acquisition was based on the closing price of $12.60 on October 24, 2025, resulting in an aggregate market value of $19...

The Hart Family Trust U/T/A DTD 10/24/2013 has filed a Form 144 with the SEC regarding the planned sale of 40,000 common shares of StepStone Group Inc. The shares were acquired on 12/02/2024 as Founders Shares. The notice date for this filing is 10/27/2025, and the plan adoption date is 11/21/2024. The aggregate market...

The filing details the stock transactions of Michael L. Richards, an officer at State Street Corp. It includes the vesting of restricted stock acquired on multiple dates: 776 shares on 02/15/2020, 494 shares on 05/15/2021, 14 shares on 02/25/2022, and 216 shares on 11/15/2022. Additionally, it reports the sale of 1,000...

The filing details the stock transactions of Gail Goodman, a director at Shopify Inc. On October 27, 2025, Goodman exercised stock options to acquire 3,200 Class A shares. The aggregate market value of these shares was $553,440, calculated using the closing price of $172.95 per share on October 24, 2025. Additionally, ...

Christopher Calio, an officer at RTX Corp, has filed a Form 144 indicating the sale of 4,813 shares of common stock. The shares were acquired through a SAR (Stock Appreciation Rights) exercise on October 27, 2025, and were sold on the same date. The aggregate market value of the shares sold is approximately $858,254. T...

Dirk A. Kempthorne, a director at Robert Half Inc., has filed a Form 144 with the SEC indicating his intention to sell 6,505 shares of common stock. The shares were acquired as vested restricted stock grants from the issuer. The sale is expected to take place on or around October 24, 2025, with an aggregate market valu...

The UTTARA SIVARAM LIVING TRUST, an affiliate of QuantumScape Corporation, has filed a Form 144 notice indicating the intent to sell 30,000 shares of Class A Common stock. The shares were acquired on February 18, 2025, through restricted stock vesting under a registered plan. The approximate sale date is October 27, 20...

The Varun Sivaram Living Trust has filed a Form 144 with the SEC, indicating the intention to sell 30,000 shares of QuantumScape Corporation's Class A Common stock. The shares were acquired through restricted stock vesting under a registered plan on February 15, 2024, and February 21, 2024. The notice date for this fil...

The Saya Sivaram Living Trust, an affiliate of QuantumScape Corporation, has filed a Form 144 with the SEC indicating the sale of 30,000 shares of Class A Common stock. The shares were sold on October 24, 2025, for a total value of $498,306. The Trust had previously acquired these shares through restricted stock vestin...

Rajeev Goel, an officer of Pubmatic, Inc., has filed a notice regarding the sale of securities under a Rule 10b5-1 plan adopted on March 2, 2025. The plan involves the sale of 44,000 common shares acquired upon option exercise on October 27, 2025. The sales are executed by the Goel Family Trust DTD 09/25/2012. In the p...

Patrick Jermain, an officer of Plexus Corp., has filed a Form 144 notice indicating his intention to sell 1,998 shares of common stock acquired as performance shares on February 12, 2019. The approximate sale date is October 27, 2025, with an aggregate market value of $285,314.40. Additionally, Jermain has recently sol...

EFSTATHIOS A KOUNINIS, an officer of Pegasystems Inc., exercised options to acquire 4,425 shares of common stock on October 27, 2025, under a registered plan. The shares were acquired for cash, and the aggregate market value of the securities to be sold is $297,581.25. Additionally, Kouninis sold a total of 7,938 share...

On October 27, 2025, Gary Hattersley, an officer at Nuvation Bio Inc, exercised stock options to acquire 100,000 shares of common stock. The transaction was executed at a market value of $485,000. The stock options were originally granted on June 24, 2024. The shares were acquired from the issuer, Nuvation Bio Inc, and...

Matthew Shair, a director at Nuvalent Inc, has filed a notice to sell 64,350 Class A Common shares acquired on February 17, 2017, as part of the Founder Shares. The sale is planned for October 27, 2025, with J.P. Morgan Securities LLC acting as the agent. The aggregate market value of the shares to be sold is $6,435,00...